From owner-molmodel@hgmp.mrc.ac.uk  Mon Oct  2 16:16:30 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 1B58917ACB; Mon,  2 Oct 2000 16:16:30 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id A195C17A77; Mon,  2 Oct 2000 16:16:28 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 03AFA415DC
	for <molmodel-list@hgmp.mrc.ac.uk>; Mon,  2 Oct 2000 16:16:27 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id QAA20317
	for molmodel-list@hgmp.mrc.ac.uk; Mon, 2 Oct 2000 16:16:27 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
Message-ID: <39D8A6C9.37D57C2F@ks.uiuc.edu>
From: Jim Phillips <jim@ks.uiuc.edu>
X-Mailer: Mozilla 4.74 [en] (X11; U; SunOS 5.7 sun4u)
X-Accept-Language: en
MIME-Version: 1.0
X-Newsgroups: bionet.molec-model
Subject: NAMD 2.2 Release Announcement
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
Lines: 39
Date: Mon, 02 Oct 2000 10:16:25 -0500
X-Complaints-To: abuse@uiuc.edu
X-Trace: vixen.cso.uiuc.edu 970499736 130.126.120.129 (Mon, 02 Oct 2000 10:15:36 CDT)
Organization: University of Illinois at Urbana-Champaign
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

+--------------------------------------------------------------------+
|                                                                    |
|                   NAMD 2.2 Release Announcement                    |
|                                                                    |
+--------------------------------------------------------------------+

                                                   September 29, 2000

The Theoretical Biophysics Group at the University of Illinois is
proud to announce the public release of a new version of NAMD, a
parallel, object-oriented molecular dynamics code designed for
high-performance simulation of large biomolecular systems.  NAMD is
distributed free of charge and includes source code.  NAMD development
is supported by the NIH National Center for Research Resources.

NAMD 2.2 has several advantages over NAMD 2.1:

- New ports to the IBM RS/6000 SP, Alpha Linux, and Windows.

- Parallelized particle mesh Ewald FFT and reciprocal space sum
  with demonstrated scaling to 128 processors for large systems.

- Release binaries contain FFTW (under special license) for
  better serial performance when using particle mesh Ewald.

- Much faster minimizer based on conjugate gradient method, also
  more stable when dealing with very bad initial contacts.

- Improved load balancer with demonstrated scaling to over
  1024 processors for large cutoff systems.

NAMD is available from http://www.ks.uiuc.edu/Research/namd/.

The Theoretical Biophysics group encourages NAMD users to be closely
involved in the development process through reporting bugs, contributing
fixes, periodical surveys and via other means.  Questions or comments
may be directed to namd@ks.uiuc.edu.

We are eager to hear from you, and thank you for using our software!




From owner-molmodel@hgmp.mrc.ac.uk  Thu Oct  5 01:54:49 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id AAE5517AC2; Thu,  5 Oct 2000 01:54:48 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id A5F1017AC1; Thu,  5 Oct 2000 01:54:46 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 7D5E9415DC
	for <molmodel-list@hgmp.mrc.ac.uk>; Thu,  5 Oct 2000 01:54:45 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id BAA29054
	for molmodel-list@hgmp.mrc.ac.uk; Thu, 5 Oct 2000 01:54:45 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
X-Newsgroups: sci.techniques.mag-resonance,aus.mathematics,bionet.molec-model
Subject: Post doc in Australia with Andrew Torda, biolomolecular calculations
Reply-To: Andrew.Torda@anu.edu.au
Organization: Research School of Chemistry, Australian National University
X-Newsposter: Pnews 4.0-test50 (13 Dec 96)
From: torda@rsc.anu.edu.au (Andrew Torda)
X-Original-NNTP-Posting-Host: 150.203.35.97
Message-ID: <39dbd14f$1@clarion.carno.net.au>
Date: 5 Oct 2000 11:54:39 +1000
X-Trace: 5 Oct 2000 11:54:39 +1000, 150.203.35.97
Lines: 58
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

POST DOCTORAL POSITION
in Canberra, Australia with Andrew Torda.

Each year, the Research School of Chemistry at the
Australian National University has a series of post-doctoral
fellowships awarded on a competitive basis. Applications for
the current round will be taken until about Oct 31 2000.
Starting dates are negotiable.

There are positions in several groups.  This ad describes my
group.

The research group of Andrew Torda is oriented towards
biomolecular calculation and simulation. We are working in
areas such as low-resolution (protein fold recognition) force
fields and mixing knowledge-based force fields and
experimental data. Most recent work has moved towards the
border of the high fashion area, bioinformatics and the nice
reliable area of force fields. We are a Boltzmann-free zone
(our force fields are much more entertaining).
Have a look at
     http://www.rsc.anu.edu.au/~torda
If you follow the link to publications, it will give you an
idea of recent work. There is also a link to an HTML version
of this text.

All the projects in the group involve coding - not just
applications.  It would be an advantage to have a reasonable
knowledge of data structures and algorithms and programming
experience in a civilized language (not fortran).
Some knowledge of graph theory would not be a disadvantage.

Salary: A$39,316 - A$47,444 per annum. Grants are provided
towards travel and removal.  Positions are initially for two
years with a likely extension to a third year.

The Research School of Chemistry is part of the Institute of
Advanced Studies which runs special research schools, in
parallel to the normal teaching schools, and without any
undergraduate teaching duties. The university is in the centre
of Canberra (the nation's capital).

Given the research orientation of the school, there is a
lively academic environment. We have close contacts with the
school's other theoretical groups in statistical mechanics,
quantum chemistry and chemical physics. From the point of view
of experimental groups, we maintain close ties to the school's
NMR, X-ray crystallography and molecular biology groups.

A final application must reach the school office by slow mail,
but initially, contact me directly.
The formal advertisement is at
 http://www.rsc.anu.edu.au/RSC/Positions/AcademicPositions/PDFadvert_sep2000.html

------------
Andrew Torda
    Research School of Chemistry, ANU, ACT 0200, Australia
    Andrew.Torda@anu.edu.au   http://www.rsc.anu.edu.au/~torda




From owner-molmodel@hgmp.mrc.ac.uk  Thu Oct  5 01:58:33 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 7529F17B7E; Thu,  5 Oct 2000 01:58:32 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 4B9C817B7C; Thu,  5 Oct 2000 01:58:31 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 9449F415DD
	for <molmodel-list@hgmp.mrc.ac.uk>; Thu,  5 Oct 2000 01:58:30 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id BAA29065
	for molmodel-list@hgmp.mrc.ac.uk; Thu, 5 Oct 2000 01:58:30 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
X-Newsgroups: sci.techniques.mag-resonance,aus.mathematics,bionet.molec-model
Subject: cancel
Control: cancel <39dbd14f$1@clarion.carno.net.au>
From: torda@rsc.anu.edu.au (Andrew Torda)
X-Original-NNTP-Posting-Host: 150.203.35.97
Message-ID: <39dbd221@clarion.carno.net.au>
Date: 5 Oct 2000 11:58:09 +1000
X-Trace: 5 Oct 2000 11:58:09 +1000, 150.203.35.97
Organization: Australian National University
Lines: 2
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

<39dbd14f$1@clarion.carno.net.au> was cancelled from within trn.




From owner-molmodel@hgmp.mrc.ac.uk  Thu Oct  5 02:00:39 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 6722817B7F; Thu,  5 Oct 2000 02:00:39 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 42A5A17B7E; Thu,  5 Oct 2000 02:00:38 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 967B0415DA
	for <molmodel-list@hgmp.mrc.ac.uk>; Thu,  5 Oct 2000 02:00:37 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA29070
	for molmodel-list@hgmp.mrc.ac.uk; Thu, 5 Oct 2000 02:00:37 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
X-Newsgroups: sci.techniques.mag-resonance,aus.mathematics,bionet.molec-model
Subject: Post doc in Australia with Andrew Torda, biomolecular calculations
Reply-To: Andrew.Torda@anu.edu.au
Organization: Research School of Chemistry, Australian National University
X-Newsposter: Pnews 4.0-test50 (13 Dec 96)
From: torda@rsc.anu.edu.au (Andrew Torda)
X-Original-NNTP-Posting-Host: 150.203.35.97
Message-ID: <39dbd2ae$1@clarion.carno.net.au>
Date: 5 Oct 2000 12:00:30 +1000
X-Trace: 5 Oct 2000 12:00:30 +1000, 150.203.35.97
Lines: 58
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

POST DOCTORAL POSITION
in Canberra, Australia with Andrew Torda.

Each year, the Research School of Chemistry at the
Australian National University has a series of post-doctoral
fellowships awarded on a competitive basis. Applications for
the current round will be taken until about Oct 31 2000.
Starting dates are negotiable.

There are positions in several groups.  This ad describes my
group.

The research group of Andrew Torda is oriented towards
biomolecular calculation and simulation. We are working in
areas such as low-resolution (protein fold recognition) force
fields and mixing knowledge-based force fields and
experimental data. Most recent work has moved towards the
border of the high fashion area, bioinformatics and the nice
reliable area of force fields. We are a Boltzmann-free zone
(our force fields are much more entertaining).
Have a look at
     http://www.rsc.anu.edu.au/~torda
If you follow the link to publications, it will give you an
idea of recent work. There is also a link to an HTML version
of this text.

All the projects in the group involve coding - not just
applications.  It would be an advantage to have a reasonable
knowledge of data structures and algorithms and programming
experience in a civilized language (not fortran).
Some knowledge of graph theory would not be a disadvantage.

Salary: A$39,316 - A$47,444 per annum. Grants are provided
towards travel and removal.  Positions are initially for two
years with a likely extension to a third year.

The Research School of Chemistry is part of the Institute of
Advanced Studies which runs special research schools, in
parallel to the normal teaching schools, and without any
undergraduate teaching duties. The university is in the centre
of Canberra (the nation's capital).

Given the research orientation of the school, there is a
lively academic environment. We have close contacts with the
school's other theoretical groups in statistical mechanics,
quantum chemistry and chemical physics. From the point of view
of experimental groups, we maintain close ties to the school's
NMR, X-ray crystallography and molecular biology groups.

A final application must reach the school office by slow mail,
but initially, contact me directly.
The formal advertisement is at
 http://www.rsc.anu.edu.au/RSC/Positions/AcademicPositions/PDFadvert_sep2000.html

------------
Andrew Torda
    Research School of Chemistry, ANU, ACT 0200, Australia
    Andrew.Torda@anu.edu.au   http://www.rsc.anu.edu.au/~torda




From owner-molmodel@hgmp.mrc.ac.uk  Fri Oct  6 20:53:53 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 738A717B52; Fri,  6 Oct 2000 20:53:52 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id CB1D317B51; Fri,  6 Oct 2000 20:53:49 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 45C0A415DD
	for <molmodel-list@hgmp.mrc.ac.uk>; Fri,  6 Oct 2000 20:53:49 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id UAA10759
	for molmodel-list@hgmp.mrc.ac.uk; Fri, 6 Oct 2000 20:53:48 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: johns@ks.uiuc.edu (John Stone)
X-Newsgroups: bionet.molec-model
Subject: Announce: VMD 1.6a3 is available
Message-ID: <slrn8tsbe6.4te.johns@geneseo.ks.uiuc.edu>
User-Agent: slrn/0.9.6.2 (SunOS)
Lines: 74
Date: Fri, 06 Oct 2000 19:52:57 GMT
X-Complaints-To: abuse@uiuc.edu
X-Trace: vixen.cso.uiuc.edu 970861977 130.126.120.127 (Fri, 06 Oct 2000 14:52:57 CDT)
Organization: University of Illinois at Urbana-Champaign
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

Hi,
  We have just made VMD 1.6a3 available for download on our 
software downloads page:
  http://www.ks.uiuc.edu/Development/Download/download.cgi

Brief change summary:
---------------------
VMD 1.6 Alpha 3 fixes PR 114 (Cartoon rep problems with certain
molecules), and has a bunch of small user interface improvements 
some of which were only on Windows, and some which are on all versions.
We're now providing pre-compiled binaries for Linux on PowerPC and Alpha
processors, which are new to this release.  I intend to continue providing
these binaries as long as we have access to such machines.  We have also
recently started adding Python support into VMD, although it isn't visible
in the binary distributions we're making available at this time, it will
begin to be more prominent in future revs of VMD.  Those individuals curious
about Python support in VMD that are willing to play with bleeding edge code
may feel free to send us email and get in on the ground floor of VMD's Python
support.  

What's new in VMD 1.6?
----------------------
  New Features
    o New support for Linux on Alpha processors
    o New support for Linux on PowerPC processors
    o New support for generation of RenderMan .RIB files from VMD scenes.
    o New VMD Python scripting interface (developmental stage)
    
  General Improvements and Bug Fixes
    o Windows version of VMD now implements mouse capture so that you can
      drag the mouse outside of the graphics window while doing rotations,
      translations, scaling, and other mouse dragging operations.
    o Improved interactive rendering speed of molecular surfaces by a factor 
      of two or more on most platforms.
    o Improved OpenGL materials rendering and gave VMD better looking
      default material properties.
    o Tachyon ray tracer binaries are now packaged along with VMD on all
      supported platforms.
    o Added the ability for Tcl code to capture VMD events as through
      the logfile mechanism, but through a Tcl variable, so that one VMD
      can easily remote control other VMD's through a bit of Tcl sockets code.
    o Significant speed increases for many common VMD commands, 
      many commands are 5 to 200 times faster now, using new Tcl 8.x 
      interpreter interface. 
    o Made it easier to customize size/position of the VMD command window
      on Unix versions of VMD.
    o Built with FLTK 1.0.9
    o Built with VRPN 5.01 
    o Fixed PRs: 60, 106, 108, 109, 110, 111, 112, 114

  User Interface Changes
    o New Tcl/Tk based RMSD fit GUI
    o Save state uses a GUI dialog now when possible.

  User Documentation Updates
    o Updated various sections in User's guide, particularly relating to new
      rendering features, RMSD fit, etc.
    o Started lengthy update to Programmer's guide.
    o Added commit email capability to CVS, may make it an option 
      for read-only CVS users as well.


We welcome your feedback on this latest version, tell us what you think!

Thanks!
  John Stone
  vmd@ks.uiuc.edu

-- 
NIH Resource for Macromolecular Modeling and Bioinformatics
Beckman Institute for Advanced Science and Technology
University of Illinois, 405 N. Mathews Ave, Urbana, IL 61801
Email: johns@ks.uiuc.edu                 Phone: 217-244-3349              
  WWW: http://www.ks.uiuc.edu/~johns/      Fax: 217-244-6078




From owner-molmodel@hgmp.mrc.ac.uk  Sun Oct  8 18:41:20 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id A208A17AFD; Sun,  8 Oct 2000 18:41:19 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 74D2B17AFA; Sun,  8 Oct 2000 18:41:18 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id CD274415E0
	for <molmodel-list@hgmp.mrc.ac.uk>; Sun,  8 Oct 2000 18:41:17 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id SAA01114
	for molmodel-list@hgmp.mrc.ac.uk; Sun, 8 Oct 2000 18:41:17 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Cathy Mac Mullan" <cathy99@ns.sympatico.ca>
X-Newsgroups: bionet.molec-model
Subject: enzyme
Lines: 45
X-Priority: 3
X-MSMail-Priority: Normal
X-Newsreader: Microsoft Outlook Express 5.50.4133.2400
X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4133.2400
Message-ID: <Xk2E5.37$PZ3.16047@sapphire.mtt.net>
Date: Sun, 08 Oct 2000 17:41:11 GMT
X-Complaints-To: abuse@mpoweredpc.net
X-Trace: sapphire.mtt.net 971026871 142.177.193.211 (Sun, 08 Oct 2000 14:41:11 ADT)
Organization: MPowered-Subscriber
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk



Could some help me with my English with this info? and Tell me how I could
improve it?

The results truned out the way they did because the tests that were done in
two of the experiments, tow conditions that affect an enzyme's shape wre
used wihc were pH and temperature. The pH affected enzyme activity because
of the different levels of pH used. The pH that was calculated as the
constant was neutral at seven. The differences outside the constant were a
result of the different pH levels used. Temperature afffects enzyme activity
because as the temperature is increased the reat of enzyme activity
increases, but at 37 degrees there is a constant met that shows the most
significant increases in the enzyme actvity if heated too much there is very
little enzyme activity because the constant has been exceeded and too much
heat is used and this affects the enzyme's activity.

In two of the other experiments other materials were used that affect the
reate of enzymatic reaction which are enzyme activity because test tubes two
and three were found to be the constant and, as the extract was increased
which contained the enzyme the level of enzyme activity increased. This
means that even though as the extract increases the enzyme concentration
effects the amount of enzyme activity, the constant has been exceeded. In
the experiment of denaturation the extract that was used in text tubes two
and three contained the enzyme and no denatured enzyme was used so there
could be no effect to how quickly the enzyme increased. In test tubes four
and five there were no extract used but a dnatured enzyme was used which
contains very little enzymes because of the denaturing in that enzyme. This
affects enzyme activity because the denaturing effect how many enzymes are
used. The inhibitor used was hydroxylamine which is a competitive inhibitor.
In test tubes tow and three there were an extract used which contains the
enzymes but there was no inhibitor used, this lets the enzyme activity
increase because the enzyme active site was no blocked by the inhibitor. In
thest tubes four and five there were hydroxylamine and extract. The enzyme
actvity increased very little because the hydroxylamin blocked the active
sites of the enzyme present.

The reason the results turned out as expected is because of the conditions
that effect the enzyme's shape such as pH and temperature; othere materials
available such as enzyme concentration and denaturation. Also the action of
an inhibitor affects enzyme activity. This results will occur if the above
conditions are used becuase they all affect how an enzyme functions and this
will affect how much and who enzyme activity will occur.





From owner-molmodel@hgmp.mrc.ac.uk  Tue Oct 10 02:03:13 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 9767917B34; Tue, 10 Oct 2000 02:03:10 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 1CBEC17AC4; Tue, 10 Oct 2000 02:03:06 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 583D8415DC
	for <molmodel-list@hgmp.mrc.ac.uk>; Tue, 10 Oct 2000 02:03:06 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA12098
	for molmodel-list@hgmp.mrc.ac.uk; Tue, 10 Oct 2000 02:03:05 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
X-Newsgroups: bionet.molec-model
From: Jim Phillips <jim@ks.uiuc.edu>
Subject: cancel <39D8A6C9.37D57C2F@ks.uiuc.edu>
Message-ID: <A678FA55F6D7D3118051009027E56FF820A0D3@ns-cam-mse1.im.battelle.org>
Date: Fri, 6 Oct 2000 13:05:13 -0700 
MIME-Version: 1.0
Lines: 3
X-Newsreader: Microsoft (R) Exchange Internet News Service Version 5.5.2650.12
Control: cancel <39D8A6C9.37D57C2F@ks.uiuc.edu>
Content-Type: multipart/alternative;
	boundary="----_=_NextPart_001_01C02FD0.BCA62222"
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

This message is in MIME format. Since your mail reader does not understand
this format, some or all of this message may not be legible.

------_=_NextPart_001_01C02FD0.BCA62222
Content-Type: text/plain


------_=_NextPart_001_01C02FD0.BCA62222
Content-Type: text/html

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii">
<META NAME="Generator" CONTENT="MS Exchange Server version 5.5.2652.35">
<TITLE>cancel &lt;39D8A6C9.37D57C2F@ks.uiuc.edu&gt;</TITLE>
</HEAD>
<BODY>

</BODY>
</HTML>
------_=_NextPart_001_01C02FD0.BCA62222--




From owner-molmodel@hgmp.mrc.ac.uk  Tue Oct 10 02:03:14 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id F35E217AC4; Tue, 10 Oct 2000 02:03:10 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 48C4317AD4; Tue, 10 Oct 2000 02:03:08 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id D9F62415DD
	for <molmodel-list@hgmp.mrc.ac.uk>; Tue, 10 Oct 2000 02:03:06 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA12102
	for molmodel-list@hgmp.mrc.ac.uk; Tue, 10 Oct 2000 02:03:06 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
X-Newsgroups: bionet.molec-model
From: reli@mixmail.com
Subject: cancel <TDNB5.315023$LH4.1020916@telenews.teleline.es>
Message-ID: <A678FA55F6D7D3118051009027E56FF820A0CF@ns-cam-mse1.im.battelle.org>
Date: Fri, 6 Oct 2000 13:05:12 -0700 
MIME-Version: 1.0
Lines: 3
X-Newsreader: Microsoft (R) Exchange Internet News Service Version 5.5.2650.12
Control: cancel <TDNB5.315023$LH4.1020916@telenews.teleline.es>
Content-Type: multipart/alternative;
	boundary="----_=_NextPart_001_01C02FD0.BC8985EA"
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

This message is in MIME format. Since your mail reader does not understand
this format, some or all of this message may not be legible.

------_=_NextPart_001_01C02FD0.BC8985EA
Content-Type: text/plain


------_=_NextPart_001_01C02FD0.BC8985EA
Content-Type: text/html

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii">
<META NAME="Generator" CONTENT="MS Exchange Server version 5.5.2652.35">
<TITLE>cancel &lt;TDNB5.315023$LH4.1020916@telenews.teleline.es&gt;</TITLE>
</HEAD>
<BODY>

</BODY>
</HTML>
------_=_NextPart_001_01C02FD0.BC8985EA--




From owner-molmodel@hgmp.mrc.ac.uk  Tue Oct 10 02:03:15 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 4778D17AD4; Tue, 10 Oct 2000 02:03:12 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 32CF217B26; Tue, 10 Oct 2000 02:03:09 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 55536415DC
	for <molmodel-list@hgmp.mrc.ac.uk>; Tue, 10 Oct 2000 02:03:07 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA12106
	for molmodel-list@hgmp.mrc.ac.uk; Tue, 10 Oct 2000 02:03:06 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
X-Newsgroups: bionet.molec-model
From: "y.k.y" <y.k.y@lycos.com>
Subject: cancel <8r2mfo$bcr1@imsp212.netvigator.com>
Message-ID: <A678FA55F6D7D3118051009027E56FF820A0C6@ns-cam-mse1.im.battelle.org>
Date: Fri, 6 Oct 2000 13:05:12 -0700 
MIME-Version: 1.0
Lines: 3
X-Newsreader: Microsoft (R) Exchange Internet News Service Version 5.5.2650.12
Control: cancel <8r2mfo$bcr1@imsp212.netvigator.com>
Content-Type: multipart/alternative;
	boundary="----_=_NextPart_001_01C02FD0.BC71AE66"
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

This message is in MIME format. Since your mail reader does not understand
this format, some or all of this message may not be legible.

------_=_NextPart_001_01C02FD0.BC71AE66
Content-Type: text/plain


------_=_NextPart_001_01C02FD0.BC71AE66
Content-Type: text/html

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii">
<META NAME="Generator" CONTENT="MS Exchange Server version 5.5.2652.35">
<TITLE>cancel &lt;8r2mfo$bcr1@imsp212.netvigator.com&gt;</TITLE>
</HEAD>
<BODY>

</BODY>
</HTML>
------_=_NextPart_001_01C02FD0.BC71AE66--




From owner-molmodel@hgmp.mrc.ac.uk  Tue Oct 10 02:03:16 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id B14E517B2E; Tue, 10 Oct 2000 02:03:12 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id AA03117B2E; Tue, 10 Oct 2000 02:03:09 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 7AC20415DE
	for <molmodel-list@hgmp.mrc.ac.uk>; Tue, 10 Oct 2000 02:03:07 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA12110
	for molmodel-list@hgmp.mrc.ac.uk; Tue, 10 Oct 2000 02:03:07 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
X-Newsgroups: bionet.molec-model
From: Hilton Evans <hfevans@SPAMNOT.ici.net>
Subject: cancel <hs5B5.4475$z77.272706@news.goodnet.com>
Message-ID: <A678FA55F6D7D3118051009027E56FF820A0CC@ns-cam-mse1.im.battelle.org>
Date: Fri, 6 Oct 2000 13:05:12 -0700 
MIME-Version: 1.0
Lines: 3
X-Newsreader: Microsoft (R) Exchange Internet News Service Version 5.5.2650.12
Control: cancel <hs5B5.4475$z77.272706@news.goodnet.com>
Content-Type: multipart/alternative;
	boundary="----_=_NextPart_001_01C02FD0.BC7410C0"
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

This message is in MIME format. Since your mail reader does not understand
this format, some or all of this message may not be legible.

------_=_NextPart_001_01C02FD0.BC7410C0
Content-Type: text/plain


------_=_NextPart_001_01C02FD0.BC7410C0
Content-Type: text/html

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii">
<META NAME="Generator" CONTENT="MS Exchange Server version 5.5.2652.35">
<TITLE>cancel &lt;hs5B5.4475$z77.272706@news.goodnet.com&gt;</TITLE>
</HEAD>
<BODY>

</BODY>
</HTML>
------_=_NextPart_001_01C02FD0.BC7410C0--




From owner-molmodel@hgmp.mrc.ac.uk  Tue Oct 10 02:03:17 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id C7BB917B36; Tue, 10 Oct 2000 02:03:14 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id E3E9A17B33; Tue, 10 Oct 2000 02:03:09 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 299D0415D5
	for <molmodel-list@hgmp.mrc.ac.uk>; Tue, 10 Oct 2000 02:03:08 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA12114
	for molmodel-list@hgmp.mrc.ac.uk; Tue, 10 Oct 2000 02:03:07 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
X-Newsgroups: bionet.molec-model
From: Hilton Evans <hfevans@SPAMNOT.ici.net>
Subject: cancel <yr5B5.4474$z77.272724@news.goodnet.com>
Message-ID: <A678FA55F6D7D3118051009027E56FF820A0C9@ns-cam-mse1.im.battelle.org>
Date: Fri, 6 Oct 2000 13:05:12 -0700 
MIME-Version: 1.0
Lines: 3
X-Newsreader: Microsoft (R) Exchange Internet News Service Version 5.5.2650.12
Control: cancel <yr5B5.4474$z77.272724@news.goodnet.com>
Content-Type: multipart/alternative;
	boundary="----_=_NextPart_001_01C02FD0.BC7410C0"
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

This message is in MIME format. Since your mail reader does not understand
this format, some or all of this message may not be legible.

------_=_NextPart_001_01C02FD0.BC7410C0
Content-Type: text/plain


------_=_NextPart_001_01C02FD0.BC7410C0
Content-Type: text/html

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii">
<META NAME="Generator" CONTENT="MS Exchange Server version 5.5.2652.35">
<TITLE>cancel &lt;yr5B5.4474$z77.272724@news.goodnet.com&gt;</TITLE>
</HEAD>
<BODY>

</BODY>
</HTML>
------_=_NextPart_001_01C02FD0.BC7410C0--




From owner-molmodel@hgmp.mrc.ac.uk  Thu Oct 12 10:36:14 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 0EC3117B9D; Thu, 12 Oct 2000 10:36:13 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 7262417B9C; Thu, 12 Oct 2000 10:36:11 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id BAD28415D5
	for <molmodel-list@hgmp.mrc.ac.uk>; Thu, 12 Oct 2000 10:36:10 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id KAA11306
	for molmodel-list@hgmp.mrc.ac.uk; Thu, 12 Oct 2000 10:36:10 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
Message-ID: <39E58509.56799440@uibk.ac.at>
Date: Thu, 12 Oct 2000 11:32:31 +0200
From: Gunther Hebein <gunther.hebein@uibk.ac.at>
X-Mailer: Mozilla 4.7 [de] (Win98; I)
X-Accept-Language: de
MIME-Version: 1.0
X-Newsgroups: bionet.molec-model
Subject: 1. Model of Epidermal Growt Factor Receptor's Proteine Tyr-Kinase
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Trace: 12 Oct 2000 11:36:00 +0200, zid-dial120.uibk.ac.at
Organization: University of Innsbruck, Austria
Lines: 7
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

Anyone worked on EGFR-RTK? I am searching a model of that
proteine-kinase for research of potent inhibitors, but didn't find any
in Literature. Any hints?

Thanks
Gunther Hebein




From owner-molmodel@hgmp.mrc.ac.uk  Fri Oct 13 04:27:12 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id BAA5E17B36; Fri, 13 Oct 2000 04:27:11 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 97B6117B2E; Fri, 13 Oct 2000 04:27:10 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 1C6CD415D4
	for <molmodel-list@hgmp.mrc.ac.uk>; Fri, 13 Oct 2000 04:27:10 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id EAA03010
	for molmodel-list@hgmp.mrc.ac.uk; Fri, 13 Oct 2000 04:27:09 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Cathy Mac Mullan" <cathy99@ns.sympatico.ca>
X-Newsgroups: bionet.molec-model
Subject: enzyme2
Lines: 38
X-Priority: 3
X-MSMail-Priority: Normal
X-Newsreader: Microsoft Outlook Express 5.50.4133.2400
X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4133.2400
Message-ID: <fivF5.109$R%5.16153@sapphire.mtt.net>
Date: Fri, 13 Oct 2000 03:27:07 GMT
X-Complaints-To: abuse@mpoweredpc.net
X-Trace: sapphire.mtt.net 971407627 142.177.197.187 (Fri, 13 Oct 2000 00:27:07 ADT)
Organization: MPowered-Subscriber
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

The results turned out the way they did because the tests that were done in
two of the experiments. In two of the experiments the materials were used
that affect the rate of enzymatic reaction, enzyme activity was one of the
factors affecting this reaction, because test tubes two and three were found
to have an extract containing the enzyme which increased enzyme activity.
This means that even though as the extract increases the enzyme
concentration effects the amount of enzyme activity. In the experiment of
denaturation, the extract that was used in test tubes two and three
contained no denatured enzyme with the extract which had no effect to how
quickly the enzyme activity increased. In test tubes four and five there
were no extract used but a denatured enzyme was used which contains very
little enzymes because of the denaturing in that enzyme. This affects enzyme
activity because the denaturing effects how many enzymes are used. The
inhibitor used was a hydroxyl amine. In test tubes two and three there was
an extract used which contains the enzymes but there was no inhibitor used,
this lets the enzyme activity increase because the enzyme active sites were
not blocked by the inhibitor. In test tubes four and five there were
hydroxyl amine and extract. The enzyme activity increased very little
because the hydroxyl amine blocked the active sites of the enzyme's
presents.

The reason the results turned out as expected is because of the condition
that affects enzymes' shape such as pH and temperature; and other materials
available such as enzyme concentration and denaturation. Temperature affects
enzyme activity because as the temperature is increased the rate of enzyme
activity increases. At 37 C there is a constant met that shows the most
significant increases in the enzyme activity. If heated too much there is
very little enzyme activity because the continuous enzymatic activity has
been exceeded and too much heat is used which in turn affects enzyme
activity. { Why? I don't know, this is where I need the most help with my
information} Also, the action of an inhibitor affects enzyme activity. These
results will occur if the above conditions are used because they all affect
how an enzyme functions and this will affect how much and who enzyme
activity will occur.







From owner-molmodel@hgmp.mrc.ac.uk  Sat Oct 14 04:40:35 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id F075617BC1; Sat, 14 Oct 2000 04:40:34 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 81AC517BBF; Sat, 14 Oct 2000 04:40:33 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id EFAC1415D5
	for <molmodel-list@hgmp.mrc.ac.uk>; Sat, 14 Oct 2000 04:40:32 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id EAA29303
	for molmodel-list@hgmp.mrc.ac.uk; Sat, 14 Oct 2000 04:40:32 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: lyvqhs@aol.com
X-Newsgroups: bionet.molec-model
Subject: Time Warner or AOL busting your balls? BUST BACK! Message the FCC with your comment! LINK to F.C.C. HERE!  9438
Lines: 220
Message-ID: <HAQF5.19255$Ri3.72475@news2.atl>
Date: Sat, 14 Oct 2000 03:40:23 GMT
X-Trace: news2.atl 971494823 216.76.215.120 (Fri, 13 Oct 2000 23:40:23 EDT)
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

The merger between AOL & Time Warner will be approved -  
BUT - the F.C.C. is going to require some form of open access.
The question is - open access for WHOM? Will the conditions 
protect ONLY THE CORPORATIONS or will they also protect YOU 
the END USER?

This is what AOL and Time Warner have to say about censorship 
and speed capping:

IF TIME WARNER DETERMINES THAT THE SUBSCRIBER HAS FAILED TO 
COMPLY WITH THE SERVICE'S STANDARDS OF CONDUCT OR LIMITS ON 
BANDWIDTH UTILIZATION, TIME WARNER MAY SUSPEND SUBSCRIBER'S 
ACCOUNT.  TIME WARNER COMMUNICATIONS SHALL HAVE THE SOLE AND 
UNREVIEWABLE RIGHT TO DETERMINE WHETHER CONTENT VIOLATES 
THESE STANDARDS.

DID YOU KNOW:

AOL cancelled the account of the President of the Chemically 
Disabled Americans - they said it was a commercial usage!  The 
president ran it from his bedroom.  As a public service.  His 
comment expressing his outrage is contained in the F.C.C. file.

DID YOU KNOW:  

These are the things that Colette Lantelme, Security Administrator 
of Road Runner, claims are against the Road Runner Acceptable Use 
Policy.

1.  Posting a message on any "For Sale" message board.
2.  Listing a product on any Ebay, Ubid, or similar service. (Boy, is 
    EBAY gonna be PISSED!)
3.  Announcing a job availability.
4.  Replying to a job availability.
5.  Mentioning that the user had tried any product and found 
    it satisfactory - or unsatisfactory.
6.  Posting a message to any "personals" board.
7.  Asking a user for a date.  
8.  Calling attention to any commercial or non-commercial 
    website, including personal websites provided as part 
    of the purchase price of the service sold by Time-Warner.  
9.  Calling attention to any IRC chat channel.  

Want to say that Al Gore can't be elected because he is a democrat?
No problem!  Want to say that Leiberman can't be elected because he
is Jewish? BANNED FROM AOL!

A very small effort on your part can well induce the F.C.C. to 
outlaw this censorship and Speed Capping, and protect YOU as well 
as the corporations.  You have some powerful allies; Consumer's Union, 
Disney, and many commercial software companies.  Even the Attorney 
General of the State of Connecticut is on YOUR side - you may read 
their petitions at the link below.  

But YOU MUST HELP!

You can F.I.L.E YOUR C.O.M.M.E.N.T IN THE O.F.F.I.C.I.A.L C.A.S.E FILE!

---> This is NOT merely a EMAIL message which will be ignored <---

Any response which you file will be an OFFICIAL document included in 
the F.C.C. FILINGS! 
It will appear in the OFFICIAL CASE FILE as a comment 
read by ALL THE ATTORNEYS who are participating in the action, as well 
as ALL THE F.C.C. C.O.M.M.I.S.S.I.O.N.E.R.S! It will remain there 
FOREVER as part of the O.F.F.I.C.I.A.L R.E.C.O.R.D of the AOL - Time 
Warner merger! With YOUR name on it!

Since this internet campaign started, approximately 250 comments have 
been received by the F.C.C from individuals.  (Some are funny as hell!)
We need twice that!

PLEASE - can you HELP PROTECT IRC and USENET?  SEND the SAMPLE COMMENT 
to the F.C.C!

The F.C.C. is on the verge of requiring the protections this letter asks 
for.  Your letter might PUSH THEM OVER THE EDGE and make the internet 
a BETTER PLACE for EVERYONE, INCLUDING YOU!

MAKE A DIFFERENCE TO USENET AND IRC!  This letter WILL MAKE A DIFFERENCE
if there are enough of them received by the F.C.C.  If at least 500
letters are received, we can probably count on the F.C.C. to take decisive
action to prohibit both censorship and speed capping - and to protect 
the users, not merely the corporations.

GET A CHAIN RESPONSE STARTED!  I can do only so much.  I can only post 
to so many newsgroups - I can't do it alone.  WE ALL NEED YOUR HELP!

Copy this message and post it to (at least) 3 newsgroups where it does 
not appear! Then, Send this message by EMAIL to (at least) 5 friends!
If everyone does that, we can FLOOD THE F.C.C. with comments and THEY 
WILL LISTEN!  

The major ccorporations and the politicians are coonducting this merger
on their terms, for their benefit, and giving no thought whatsoever to 
the users. They are all fighting over our dollars, but do they give any 
concern whatsoever to us?  Does a fish ride a bicycle?

They believe that the internet, which WE, not them, made great, is now 
too valuable to be left the users.  Their attitude is, "let them comment, 
they don't count, they are not rich corporations, they are merely poor 
users.  Will YOU let them get away with this?

They can ignore 250 users.  They can't ignore thousands of users.

Right now our comments, all 250 of them, are a minor agravation to
the "power structure."  They have to wade through them to get to the 
important stuff, the corporate, I.E. money, responses.

THOUSANDS OF COMMENTS ARE NOT AN AGRAVATION, THEY ARE A POLITICAL
PHENOMENON!  DO YOUR PART!

LET THE F.C.C. know that THE INTERNET DOSEN'T STAND FOR ANY BULL! Tell 
the F.C.C. I'M MAD AS HELL AND I'M NOT GONNA TAKE IT ANYMORE!

The future of USENET and IRC depends on the F.C.C. forcing all ISP's 
starting with Time Warner and AOL to recognize free speech and fair 
marketing practices.  PLEASE HELP!

TO FILE YOUR COMMENT WITH THE F.C.C:

1.  Copy the letter to a file.  You can put it on your letterhead 
with MS Word or just use a text file.  You can make any change to 
the letter you want, or add any comment you have.  CHANGES ARE GOOD! 
They show you READ THE LETTER and REALLY CARE!  If you had a bad 
experience with AOL or Time Warner PUT IT IN!

2.  go to:

https://gullfoss2.fcc.gov/cgi-bin/websql/prod/ecfs/upload_v2.hts 

(This is the official F.C.C. page where electronic filing of petitions 
is accomplished)

3.  Fill out Cover sheet

Put your name, Address, Email address, and all other required 
information on the form.  (Remember this is an OFFICIAL FILING so 
the F.C.C. requires this information.  It is not published unless you 
put it in the letter as well as the form)

Proceeding is 

             00 - 30 

(Leave out the spaces, they are there to get by the spam filter.  
Put in the -)

(this is VERY IMPORTANT, it is the case number of the AOL TIME 
WARNER APPLICATION for merger.  If you get it wrong, your comment 
WILL NOT BE FILED!)

4.  Send Cover Sheet.

5.  After you send the Cover Sheet, THEN select the filename of the 
letter you are sending, and send that.

6.  After you send the file, you will receive an official 
confirmation of the filing from the F.C.C.

7. You can TYPE a comment instead of sending this sample comment, but
DON'T PASTE THE SAMPLE COMMENT into the Short Comment box - it 
DOESN'T FIT! 

Comment will appear for all to read in about 4 hours 
(but won't appear after business hours or on the weekend.) 

8.  If you want to see your letter, or read the other submissions,
other letters, the AOL petition, the Disney or Consumer's Union 
objections, etc, here is the URL - Its long!  Put in the case 
number, 00 - 30 (no spaces) and nothing else.

https://gullfoss2.fcc.gov/cgi-bin/websql/prod/ecfs/comsrch_v2.hts?ws_mode=retrieve_list&id_proceeding=00-30&start=1

IF YOU LIVE N A FOREIGN COUNTRY and wish to make a comment (This is a 
world wide problem) the Cover Sheet will not accept your address.  You
can do this:  Enter your real name and address including country in
the address lines, but in the STATE box  put CA and in the ZIP (first
field) put 90001.  Ignore the 2nd zip field.  Ignore the 2nd form, and 
TYPE your SHORT COMMENT in the 3rd form. Please identify the country 
you live in the message.  Don't use the sample letter supplied 
because it isn't appropriate for non-US residents.

***>Remember the FORM INFORMATION will NOT appear, only the letter.

NOTE:  There is NO WORD WRAPPING on the letter below, to make it 
easy for you to format so it may be hard to read until you copy it,
depending on your news reader.


        SAMPLE MESSAGE

------------cut here----------------------------------------------


To the FCC Commissioners

Ladies and Gentlemen:

I am writing in response to the proposed merger of America Time Warner Communications. There are two elements in the proposal that greatly concern me. I would hope that the commissioners would carefully consider these in making their decisions.

The development and evolution of the Internet is a study in how a system without artificial limits can exceed anyone's expectations. The "rules of the road" for the information superhighway, such as they are, have been agreed upon by community consensus and is a marvelous example of market forces at work. One of the guiding principles which has evolved within this community is the open and free exchange of information, much as there is within the academic environment that fostered the early years of the Internet. The internet has always subscribed to and operated under the guarantees of the First amendment to the Constitution, without regard for questioning whether this was a legal requirement.

The proposed merger as set forth in proceeding # 00-30 will violate every principle of freedom of speech upon which the Internet has historically been based. Specifically, the combination of Time Warner and AOL will be powerful enough to establish the rules which everyone desiring high speed, and possibly any, access will be subject to, and those rules are truly alarming to those accustomed to freedom of the net.  They state:

IF TIME WARNER DETERMINES THAT THE SUBSCRIBER HAS FAILED TO COMPLY WITH THE SERVICE'S STANDARDS OF CONDUCT OR LIMITS ON BANDWIDTH UTILIZATION, TIME WARNER MAY SUSPEND SUBSCRIBER'S ACCOUNT.  TIME WARNER COMMUNICATIONS SHALL HAVE THE SOLE AND UNREVIEWABLE RIGHT TO DETERMINE WHETHER CONTENT VIOLATES THESE STANDARDS.

This language is quite frightening, given that it grants license to censor to a corporate entity not to the common good, but to bottom line economic forces. Our guarantees under the constitution were designed by its authors to be beyond those forces for good reason. They recognized that such a fundamental right to freedom could never be effectively overseen by a purely commercial, or even political, entity. I believe that the Commissioners would be well served to remember that example, and move to insure that access cannot be denied to the internet by the gatekeeper based on the content of the speech of the user.

My second concern is related, although it could never have been foreseen by our founding fathers.  Bandwidth is fundamental to the ability to communicate on the Internet. Here again, Time Warner Communication proposes to hold a noose around the available bandwidth, and, subject to their whim alone, choke off access to those they deem unacceptable.

Certainly this commission cannot order how much bandwidth they supply to their customer.  But this commission can and should insure that any company, as a condition of the privilege of merger, deliver to their customers what they promise.  A company which advertises and sells unlimited access, then terminates those who use this access, while retaining what, to them is the most profitable base, those who do not use this access, is defrauding the public.

I urge you, therefore, to consider these concerns in reaching your decision.  The easy course will be to merely accede to the demands of the corporations.  That, however, will require that someone eventually solve the problems that will inevitably result from that decision - and the person who must repair the damage may be you.

Thank you for your attention to my concerns.

----> YOUR NAME <----
jzbvrugnebqfvmohkqsuwiqsmtvpnsumxiqdsjqdvtlxgnukflqfzrfzpdkgvcrwqowttflvkzytncrzypqrfdvizy




From owner-molmodel@hgmp.mrc.ac.uk  Mon Oct 16 17:55:49 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id D7D5417B4C; Mon, 16 Oct 2000 17:55:48 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 9716D17B41; Mon, 16 Oct 2000 17:55:47 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 9E283415D4
	for <molmodel-list@hgmp.mrc.ac.uk>; Mon, 16 Oct 2000 17:55:46 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id RAA00552
	for molmodel-list@hgmp.mrc.ac.uk; Mon, 16 Oct 2000 17:55:46 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: hty@ycs.at
X-Newsgroups: bionet.molec-model
Subject: Reverse the Aging Process 10-20 years!
Date: 16 Oct 2000 17:55:45 +0100
Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre
Lines: 169
Message-ID: <20001016165542.6BD2D415D4@mercury.hgmp.mrc.ac.uk>
Mime-Version: 1.0
Content-Type: text/plain; charset=unknown-8bit
X-Trace: niobium.hgmp.mrc.ac.uk 971715345 550 193.62.192.80 (16 Oct 2000 16:55:45 GMT)
X-Complaints-To: news@net.bio.net
X-Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id A317317B41; Mon, 16 Oct 2000 17:55:43 +0100 (BST)
X-Received: from prbrgec01.gencat.es (gencat.es [194.179.95.227])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 6BD2D415D4
	for <molmodel@net.bio.net>; Mon, 16 Oct 2000 17:55:42 +0100 (BST)
X-Received: from computer (1Cust207.tnt2.fort-lauderdale.fl.da.uu.net [63.17.216.207]) by prbrgec01.gencat.es with SMTP (Microsoft Exchange Internet Mail Service Version 5.5.2448.0)
	id 4W2YL32B; Mon, 16 Oct 2000 18:36:36 +0200
X-To: hty@ycs.at
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk


HAVE YOU HEARD OF HUMAN GROWTH HORMONE (HGH)???

Released by your own pituitary gland, HGH starts
declining in your 20s, even more in your 30s and 40s,
eventually resulting in the shrinkage of major
organs-plus all other symptoms related to old age.

THIS CAN NOW BE REVERSED!!! IN THOUSANDS OF CLINICAL
STUDIES, HGH HAS BEEN SHOWN TO ACCOMPLISH THE FOLLOWING:

* Reduce Body Fat Without Dieting
   Build Lean Muscle WITHOUT EXERCISE!

* Enhance Sexual Performance

* Remove Wrinkles and Cellulite

* Lower Blood Pressure and improve Cholesterol Profile

* Improve Sleep, Vision and Memory

* Restore Hair Color and Growth

* Strengthen the Immune System

* Increase Energy and Cardiac Output

* Turn back your body's Biological Time Clock 10-20
   years in 6 months of usage !!!

You don't have to spend thousands of dollars on shots.
You don't have to spend the $139.00 per bottle that
HGH is selling for at some Clinics in the
United States.

For the next 30 Days, you can obtain a complete
one-month supply of our HGH releaser for our special
"New Customers" price of just $69.95 plus $6.00
shipping and handling. To ensure a constant supply and
to SAVE EVEN MORE, you can order with confidence
3 bottles of HGH and GET 1 FREE - that's just $209.85 for
4 bottles, plus $6.00 shipping and handling.
You SAVE $69.95! ORDER TODAY!

Payment Methods

You may FAX or Postal Mail Checks, MasterCard, Visa,
& American Express payments. Money Orders
are accepted only by Postal Mail.


Step 1: Place a check by your desired quanity.


______ 1 Bottle of HGH $69.95


______ 2 Bottles of HGH $131.90 ($65.95 a bottle)


______ 4 Bottles of HGH (Buy 3 get 1 FREE. SAVE $69.95) $209.85


Please add $6 shipping and handling for any size order.
[ Total cost including shipping & handling,
1 bottle =$75.95, 2 bottles=$137.90, 4 bottles=$215.85 ]


Step 2: Place a check by your desired payment method
and complete fields if necessary.


_____Check or CHECK-BY-FAX [details below]


_____Money Order


_____American Express
Account Number__________________ Exp____/____

_____Visa
Account Number__________________ Exp____/____

_____MasterCard
Account Number__________________ Exp____/____


Please make your check or money order payable to
"Lion Sciences National".

Step 3: Please complete and print the following fields clearly.


Name ___________________________________________________


Address _________________________________________________


City ____________________________________________________


State ___________________________________________________


Zip _____________________________________________________


E-mail __________________________________________________


Signature _________________________________________________
[ required for check and credit card orders]



            Toll Free FAX Order Line: 1-800-940-6590

If faxing in your order, please state whether you require
a fax, email, or no confirmation at all.
Allow up to one day for confirmation, if requested.
FAX orders are processed immediately.

            Or, print & mail to:

Lion Sciences National
3502 N. Powerline Rd. #525
Pompano Beach, FL 33069

        ______________________________________________________


*CHECK BY FAX ORDERS: Complete the check as normal. Tape
the check in the area below. Below the check, clearly write
the check number, all numbers at the bottom of the check,
& your name. Tape the check below and fax the check to the
toll free FAX number above. Void the check. Our merchant
will electronically debit your account for the amount of
the check; your reference number for this transaction will
be your check number. Nothing could be safer & easier !

                          TAPE CHECK BELOW
















_____________________________________________________________

This is a one time mailing: Removal is automatic and no further
contact is necessary. Please Note: HGH is not intended to
diagnose, treat, cure or prevent any disease. The FDA has not
evaluated these statements.


---




From owner-molmodel@hgmp.mrc.ac.uk  Mon Oct 16 22:58:49 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 6AE9717B0D; Mon, 16 Oct 2000 22:58:48 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 070A017B15; Mon, 16 Oct 2000 22:58:43 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 0409F415D4
	for <molmodel-list@hgmp.mrc.ac.uk>; Mon, 16 Oct 2000 22:58:42 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id WAA12910
	for molmodel-list@hgmp.mrc.ac.uk; Mon, 16 Oct 2000 22:58:42 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: amcgough@bilbo.bio.purdue.edu (Amy McGough)
X-Newsgroups: bionet.molec-model
Subject: biophysics symposium
Date: 16 Oct 2000 22:58:41 +0100
Organization: Purdue University
Lines: 42
Message-ID: <39EB7BB7.4997B08F@bilbo.bio.purdue.edu>
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii; x-mac-type="54455854"; x-mac-creator="4D4F5353"
Content-Transfer-Encoding: 7bit
X-Trace: niobium.hgmp.mrc.ac.uk 971733522 12908 193.62.192.80 (16 Oct 2000 21:58:42 GMT)
X-Complaints-To: news@net.bio.net
X-Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 2D3ED17B60; Mon, 16 Oct 2000 22:58:40 +0100 (BST)
X-Received: from bilbo.bio.purdue.edu (bilbo.bio.purdue.edu [128.210.65.126])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id D2536415D4
	for <molmodel@net.bio.net>; Mon, 16 Oct 2000 22:58:38 +0100 (BST)
X-Received: from bilbo.bio.purdue.edu (dhcp155-221.bio.purdue.edu [128.210.155.221])
	by bilbo.bio.purdue.edu (8.9.3/8.9.3) with ESMTP id QAA12102
	for <molmodel@net.bio.net>; Mon, 16 Oct 2000 16:58:37 -0500
X-Reply-To: amcgough@bilbo.bio.purdue.edu
X-Mailer: Mozilla 4.5 (Macintosh; I; PPC)
X-Accept-Language: en
X-To: molmodel@net.bio.net
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk


Dear Colleagues:

On the behalf of the Organizing Committee I would like to invite you and

your colleagues to join us for the Sixth Annual Biophysics and Cell
Biology Symposium to be held December 1st and 2nd at Purdue University
in West Lafayette, Indiana.

This student-organized Symposium represents a unique opportunity for
students to present and discuss their research at the interface of
structural and cell biology, to gain exposure to the professional
meeting format, and to attend our Industry Sponsors Luncheon and become
better informed about future career possibilities.  More information
can be found at:
http://www-structure.bio.purdue.edu/~rbernal/Symposium/

Space is limited, so if you plan to attend, please send us your
completed application materials to us as soon as possible.  We look
forward to seeing you at this exciting event!

Amy McGough, Ph.D.
Assistant Professor
Purdue University Department of Biological Sciences
1392 Lilly Hall
West Lafayette, IN 47907-1392
Fax: 765-496-1189

Student Organizing Committee:
Matt Gage
Ricardo Bernal
Dave Kovar
Sue Karagiosis
David Neau

Faculty Advisors:
Bill Cramer
Joann Otto
Amy McGough


---




From owner-molmodel@hgmp.mrc.ac.uk  Wed Oct 18 20:17:54 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id B3CCE17BC5; Wed, 18 Oct 2000 20:17:53 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 6BD7117A73; Wed, 18 Oct 2000 20:17:52 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 7860A415E2
	for <molmodel-list@hgmp.mrc.ac.uk>; Wed, 18 Oct 2000 20:17:51 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id UAA24566
	for molmodel-list@hgmp.mrc.ac.uk; Wed, 18 Oct 2000 20:17:50 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Rich Cooper" <richcooper1@mindspring.com>
X-Newsgroups: bionet.molec-model
Subject: Cell simulation software
Date: Wed, 18 Oct 2000 12:16:41 -0700
Organization: MindSpring Enterprises
Lines: 33
Message-ID: <8skst0$hcb$1@nntp9.atl.mindspring.net>
X-Server-Date: 18 Oct 2000 19:15:44 GMT
X-Priority: 3
X-MSMail-Priority: Normal
X-Newsreader: Microsoft Outlook Express 5.00.2615.200
X-MimeOLE: Produced By Microsoft MimeOLE V5.00.2615.200
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

I'm planning to convert my software product into a cellular activity
simulation product.  The researcher would specify the initial condition of
the cell, and specify the final condition, and then the software would use
genetic function databases to stitch together the sequence of activities and
objects that could drive the cell from the initial condition to the final
condition.  The researcher would then browse through the stitched together
activities that a cell might use to perform the sequence of activities.

For example, you might specify a healthy cell in the details that interest
you.  Then you might specify a cancerous cell in details using the same
vocabulary of genes, proteins, activities, and physical objects.

My background is PhD in CS&EE.  My medical engineering background is
primarily in physiology, at the organ level, with little chemical
background.  I've read all the popular genetics books, as well as Watson's
"Recombinant DNA" classic.  I'm aware of the MitoMap and the Gene Ontology
Consortium databases.  These might provide a starting vocabulary for cell
simulation specifications.

I'm looking for biochemist partners to help define what the product should
do, and how it should be provided.  If you have any interest in guiding the
directions that a cell simulation product should take, please let me know.

You can answer the post here, or you can email me directly at:
mailto:richcooper1@mindspring.com

Sincerely,
Rich Cooper








From owner-molmodel@hgmp.mrc.ac.uk  Mon Oct 23 12:33:11 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id BA11A17B3D; Mon, 23 Oct 2000 12:33:06 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 2E45717B2D; Mon, 23 Oct 2000 12:32:56 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id D8A54415E4
	for <molmodel-list@hgmp.mrc.ac.uk>; Mon, 23 Oct 2000 12:26:41 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id MAA28635
	for molmodel-list@hgmp.mrc.ac.uk; Mon, 23 Oct 2000 12:26:41 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: info@seriousmonkey.com
X-Newsgroups: bionet.molec-model
Subject: -  Major automotive website <93756026>
Date: Sun, 22 Oct 2000 12:24:59 +0000
Organization: UUNET WorldCom server (post doesn't reflect views of UUNET WorldCom
Lines: 112
Message-ID: <8t17cm$jhp$648@lure.pipex.net>
X-Trace: lure.pipex.net 972300502 20025 62.188.134.80 (23 Oct 2000 11:28:22 GMT)
X-Complaints-To: abuse@uk.uu.net
X-Newsreader: seriousmonkey.com News Poster 54694732
ReplyTo: info@seriousmonkey.com
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk


seriousmonkey.com is set to revolutionise the global automotive 
industry with a wide range of genuinely groundbreaking and innovative 
Internet services benefiting business and consumers alike.

In order to support the hyper-growth expansion of our global operations, 
seriousmonkey.com will shortly be looking for a number of high-calibre, 
professional candidates to join our fast-paced and dedicated teams in 
London and the Republic of Ireland.

To visit seriousmonkey.com or view our online job vacancies, go to 
http://www.seriousmonkey.com

Frank Pottle
Managing Director
seriousmonkey.com


















































Article posted 23/10/2000 12:24:59.300
















































From owner-molmodel@hgmp.mrc.ac.uk  Wed Oct 25 16:39:23 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 814AA17BBC; Wed, 25 Oct 2000 16:39:21 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 3685817BBB; Wed, 25 Oct 2000 16:39:15 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 46E7F415E8
	for <molmodel-list@hgmp.mrc.ac.uk>; Wed, 25 Oct 2000 16:30:15 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id QAA24061
	for molmodel-list@hgmp.mrc.ac.uk; Wed, 25 Oct 2000 16:30:13 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: software@mail.cryst.bbk.ac.uk
X-Newsgroups: bionet.molec-model
Subject: Protein Crystallography on the Web
Date: Wed, 25 Oct 2000 15:16:36 GMT
Organization: Deja.com - Before you buy.
Lines: 19
Message-ID: <8t6tgc$dkn$1@nnrp1.deja.com>
X-Article-Creation-Date: Wed Oct 25 15:16:36 2000 GMT
X-Http-User-Agent: Mozilla/4.72 [en] (X11; U; Linux 2.3.99-pre9 i686)
X-Http-Proxy: 1.0 x59.deja.com:80 (Squid/1.1.22) for client 193.61.34.8
X-MyDeja-Info: XMYDJUIDda5e
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

Advanced Certificate in Protein Crystallography on the Web 2000/2001

              Web site: http://px.cryst.bbk.ac.uk/

This is a brief reminder that this protein crystallography course will
soon be starting its fourth year intake, with the final deadline for
enrolment being 29/11/00.

The course is delivered via the Internet and makes use of innovative
technologies for distance learning. The course is ideally suited to the
biologically orientated scientist who wants to know in more detail
(mainly
non-mathematical) how structures are determined, how the quality of
coordinates should be judged, and how crystallographic papers should be
assessed. Please browse the above URL for further details.


Sent via Deja.com http://www.deja.com/
Before you buy.




From owner-molmodel@hgmp.mrc.ac.uk  Sat Oct 28 12:06:18 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 9930917ADA; Sat, 28 Oct 2000 12:06:17 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id 5DDA117AC2; Sat, 28 Oct 2000 12:06:16 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 6B366415DC
	for <molmodel-list@hgmp.mrc.ac.uk>; Sat, 28 Oct 2000 12:06:12 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id MAA09362
	for molmodel-list@hgmp.mrc.ac.uk; Sat, 28 Oct 2000 12:06:11 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Hilton Evans" <hfevans@ici.net>
X-Newsgroups: bionet.molec-model
Subject: Molecular Mechanics Software
Lines: 2
MIME-Version: 1.0
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
X-Priority: 3
X-MSMail-Priority: Normal
X-Newsreader: Microsoft Outlook Express 5.50.4133.2400
X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4133.2400
Message-ID: <AqyK5.208$z93.37898@news.goodnet.com>
Date: Sat, 28 Oct 2000 07:06:06 -0400
X-Complaints-To: abuse@winstar.net
X-Trace: news.goodnet.com 972731168 207.180.17.110 (Sat, 28 Oct 2000 04:06:08 MST)
Organization: WinStar GoodNet, Inc.
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

http://home.ici.net/~hfevans/chempen3.htm




From owner-molmodel@hgmp.mrc.ac.uk  Sat Oct 28 12:07:06 2000
Return-Path: <owner-molmodel@hgmp.mrc.ac.uk>
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id C15C317AE7; Sat, 28 Oct 2000 12:07:05 +0100 (BST)
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6024)
	id F38C417ADA; Sat, 28 Oct 2000 12:07:03 +0100 (BST)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id DB39A415E1
	for <molmodel-list@hgmp.mrc.ac.uk>; Sat, 28 Oct 2000 12:06:55 +0100 (BST)
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id MAA09366
	for molmodel-list@hgmp.mrc.ac.uk; Sat, 28 Oct 2000 12:06:55 +0100 (BST)
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Hilton Evans" <hfevans@ici.net>
X-Newsgroups: bionet.molec-model
Subject: C-13 NMR Shift Java Applet
Lines: 2
MIME-Version: 1.0
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
X-Priority: 3
X-MSMail-Priority: Normal
X-Newsreader: Microsoft Outlook Express 5.50.4133.2400
X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4133.2400
Message-ID: <bryK5.209$z93.37878@news.goodnet.com>
Date: Sat, 28 Oct 2000 07:06:46 -0400
X-Complaints-To: abuse@winstar.net
X-Trace: news.goodnet.com 972731207 207.180.17.110 (Sat, 28 Oct 2000 04:06:47 MST)
Organization: WinStar GoodNet, Inc.
To: molmodel@hgmp.mrc.ac.uk
Sender: owner-molmodel@hgmp.mrc.ac.uk
Precedence: bulk

http://home.ici.net/~hfevans/jnmrpen.htm